Regeneron Pharmaceuticals $REGNhas been in a sharp bearish market since price fell from $540 a share in 2017. It is holding above $280 for now but could extend if the prevailing bearish momentum continues. I think there is a case to buy on this dip as price approaches $275.
Regeneron Pharmaceuticals (REGN) - The Case for Buying on the Dip
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться